SUMMARY During periods of tachycardia induced by atrial pacing in eight patients, moderate increments in dP/dt(max) and (dP/dt)/CPIP (common produced intraventriciilar pressure) and moderate reductions in left ventricular ejection time (LVET) and Q-S2 were demonstrated. These changes varied between individuals, but reduction in systolic intervals was consistently less than that reported from populations showing a range of resting heart rates. Individual regression formulae relating each variable to paced heart rate were used to calculate rate-dependent and rate-independent changes induced by isoprenaline and ouabain. Despite technical difficulty in precise measurement of systolic intervals, there was an excellent inverse correlation between rate-independent changes in Q-S2 and in both dP/dt(max) and (dP/dt)/CPIP. Rate-independent change in Q-S2 appears to be a practical, moderately sensitive, and reasonably precise measure of the inotropic effect of a drug which does not radically alter left ventricular end-diastolic pressure or blood pressure; Day-to-day variation in systolic intervals may limit the use of the technique to studies of short duration.
Determination of the inotropic activity of a drug essentially belongs to the animal laboratory, but confirmation of this activity, and particularly characterisation of its dose-response effects in man, is a necessary prelude to its rational clinical employment. Direct measurement of changes in contractile activity and pumping function of the left ventricle presently furnish the most accurate indication of alterations in inotropic activity.1-3 Cardiac catheterisation, however, is cumbersome, limited by ethical considerations, and often of such brevity as to preclude the measurement of duration of activity of a drug or its dose-response effects. Non-invasive methods have therefore been sought as a means of making repeated measurements of left ventricular activity; among such methods measurement of the duration of the various components of systole has been the most widely acclaimed.46 The utility of these methods, however, in evaluating changes in left ventricular activity induced by drugs has yet to be fully tested. It was the purpose of this study, therefore, to evaluate the precision by which measurements of non-invasive systolic time intervals * Present address: Division of Clinical Pharmacology, University of Massachusett Medical Center, Worcester, Massachusetts 01605, USA Received for publication 5 June 1981 reflect changes in intraventricular pressure before and after the administration of drugs known to increase motropic activity.
Subjects and methods
Four normal subjects (aged 20 to 35 years), and six male and two female patients (aged 23 to 45 years) admitted for the investigation of chest pain were studied. All were in sinus rhythm. In the patients, radiographic cardiac silhouette was normal. Electrocardiograms at rest and during treadmill exercise up to heart rates of 160 beats per minute were normal in all. Left ventricular end-diastolic pressure during supine leg exercise did not exceed 25 mmHg. None was receiving drugs at the time of the study. Informed consent was obtained from all patients.
DESIGN OF INVESTIGATION
The four normal subjects were used to determine the day-to-day variation in systolic time intervals. Measurements were made on separate days at the same time each morning two hours after a light breakfast without tea or coffee and after they had been tts. quietly reclining for 20 minutes.
Patients were studied resting supine without sedation two hours after a light meal. Left ventricular 5Johnson, Meeran, Frank, Taylor catheterisation was performed by the percutaneous Seldinger technique via the right brachial artery using a (55 xO0 1 cm) red Portex nylon catheter with a frequency response of 40 Hz. Pressure was transduced by a strain-gauge manometer (SEM 482), the output being recorded on a multichannel ultraviolet recorder (SEM 3012). The common zero reference level for all pressures was set at 10 cm below the sternal angle and calibrated over the range 0 to 100 mmHg. Linearity of the manometers was checked before each study, and zero and calibration checks were made before and after each period of study. The left ventricular catheter was intermittently flushed from a reservoir with heparinised saline. The first derivative of left ventricular pressure (dP/dt) was computed continuously with an R-C differentiating circuit with a time constant of 4 7x 10-3 mmHg/cm per s. A bipolar pacing catheter (USCI SF United States Catheter Co.) was introduced through a right brachial vein and positioned at the junction of the superior vena cava and right atrium. Simultaneously with left ventricular pressure measurements, recordings were made of the electrocardiogram, phonocardiogram, and carotid arterial pulsations at a paper speed of 100 mm/second.
The electrocardiogram was recorded from adhesive-disc electrodes applied to each shoulder, the lower rib-cage, and the V5 position, calibrated externally (1 mm=0 1 mV), and recorded on an ultraviolet recorder (SE Laboratories Model 3012). Lead II was employed for systolic time interval measurements.
A microphone (Siemen-Elema AB, Stockholm) was placed over the upper praecordium in the best position for recording the initial high frequency vibrations of the first and second heart sounds and connected to a preamplifier (SEM 4902). Recordings were made in a frequency band of 100 to 500 Hz.
The carotid arterial pulsation was recorded with a Philips Displacement Pick-Up 9310, which measured static and dynamic relative displacements, and connected to a Philips PT 1200 amplifier with a time constant of 1 0 s and a frequency range set at 0-100 Hz. Recordings were made with the head tilted towards the contralateral shoulder.
The obligatory requirements for recordings were a steady electrocardiographic baseline, sharp inscription of the initial vibrations of the first and second heart sounds, a sharp upstroke and clear incisural notch on the carotid arterial pulse tracing, and a clear atrial component of the left ventricular pressure measurements.
Studies were made at rest; control measurements were obtained after the patient had been lying quietly for Hence, the common produced intraventricular pressure was 40 mmHg in every cycle. This determined level of intraventricular pressure was consistently below aortic diastolic pressure throughout each experiment. Average values of dP/dt recorded at this intraventricular pressure were again derived from 10 consecutive beats, and the ratio (dP/dt)/CPIP calculated at dP/dt divided by 40 mmHg. The ventricular end-diastolic pressure was measured at the nadir of the ventricular pressure recording after the atrial systolic increment.
Non-invasive techniques
The Q-S2 interval (duration of electromechanical systole) was measured from the onset of ventricular depolarisation (Q wave) to the first high frequency vibration of the aortic component of the second heart sound. Left ventricular ejection time was measured from the beginning of the rapid upstroke to the trough of the incisural notch of the carotid arterial pulse tracing. Pre-ejection period was calculated by subtraction of left ventricular ejection time from Q-S2: this interval corresponds with the beginning of ventricular depolarisation to the start of left ventricular ejection.
From the photographic records, time intervals were determined in milliseconds with the assistance of a D-MAC computer linkage, programmed to derive and print out heart rate, individual intervals, and their mean ± standard error for each selected series of heart beats. Series of 15 to 20 consecutive beats were selected, as it was found that a minimum of 12 individual beats was required before the observed mean value changed less than 3% with the addition of a further beat. Systolic time indices corrected for heart rate9 were also derived, but were not analysed in detail for reasons explained later.
Results

VARIATION IN SYSTOLIC TIME INTERVALS IN
NORMAL SUBJECTS (Table 1) In all four normal subjects there was considerable day-by-day variation in heart rate and systolic time intervals, despite the fact that they were entirely familiar with the procedure and that the measurements were made at the same time each day and under identical laboratory conditions. Moreover, there was little within-subject correspondence between changes in heart rate and duration of electromechanical systole (Q-S2), ejection phase, or pre-ejection time. There was an inverted relation between changes in heart rate and directional changes in systolic time intervals at some point in each subject. Neither variable showed any between-subject relation to heart rate (range 71 to 90 beats/min). Left ventricular end-diastolic pressure was 11±1 5 mmHg. Simultaneous measurements of Q-S2, left ventricular ejection time, and pre-ejection period were 380±5, 284±5, and 96±5 ms, respectively. Atrial pacing (Table 2) During atrial pacing there was a tendency to reduction in left ventricular end-diastolic pressure and a stepwise increase in dP/dt (max) and (dP/dt)/CPIP in almost all subjects. There was a predictable linear relation between the increase in paced heart rate and both of the latter measurements ( Fig. 1 and 2 ).
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Isoprenaline infusion (Table 3) Infusion of isoprenaline was associated with increases in heart rate of 41 to 65 beats per minute in six subjects, but in two others the maximal heart rate increases were 9 and 17 beats/min despite an infusion rate of 12 ,ug/min. In all subjects there was a consistent stepwise reduction in left ventricular enddiastolic pressure together with a stepwise increase in dP/dt (max) and (dP/dt)/CPIP. There was a significant linear relation between the increase in heart rate and both of the latter measurements, the changes after isoprenaline being significantly greater 40. than those associated with pacing-induced increases in heart rate ( Fig. 1 and 2 ).
Likewise the reductions in Q-S2, left ventricular ejection time, and pre-ejection period at given increases in heart rate were significantly greater after isoprenaline than during pacing (Fig. 3, 4 , and 5). Table 4 compares the regression relations between changes in these variables and increases in heart rate. In each case, the regression slope was significantly greater for isoprenaline than for pacing-induced increases in heart rate.
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Fig. 2 Comparison ofgroup regression lines relating increases in (dP/dt)/CPIPand heart rate during atrial pacing and isoprenaline infusion.
Fig. 4 Comparison ofgroup regression lines relating decrease in LVET with increase in heart rate during atrial pacing and isoprenaline infusion. Rate-independent changes It was assumed that the inotropic component of an isoprenaline-induced change equalled the difference between values recorded at the same heart rate during pacing and during isoprenaline infusion. This measure was termed the rate-independent rise for dP/dt (max) and (dP/dt)/CPIP, and the rateindependent reduction for Q-S2 and LVET. As the regression relation between each variable and electrically induced change in heart rate varied between individual patients, rate-independent changes were calculated separately for each patient. For ouabain, rate-independent changes were calculated after extending the regression relation between each variable and paced heart rate to the lower heart rates recorded after ouabain.
Excellent correlations were shown within the patient group between the various rate-independent changes induced by drugs. For isoprenaline, rateindependent reduction in Q-S2 correlated well with rate-independent rise in dP/dt (max) (r= -0 68, p<0001) and in (dP/dt)/CPIP (r=-0 75, p<0 001), and rate-independent reduction in left ventricular ejection time was also well correlated (r=-0-68, p<0001) for both dP/dt (max) and (dP/dt)/CPIP. For pooled data from both isoprenaline and ouabain experiments the correlations were highly similar to the above values for isoprenaline alone. Fig . 6 , the true relation between rate-independent changes in dP/dt (max) and Q-S2 appeared curvilinear over a wide range of isoprenaline induced effects. Over the smaller range of effects induced by ouabain alone, lesser degrees of correlation were observed. As illustrated in Fig. 7 , there was no significant correlation between rate-independent changes in Q-S2 and dP/dt (max) (r=-0-34, p>005), and rate-independent reduction in left ventricular ejection time showed only a modest correlation with dP/dt (max) (r= -0A44, p<005). As opposed to isoprenaline effects, however, rateindependent changes in dP/dt (max) after ouabain were only moderately correlated with (dP/dt)/CPIP (r=045, p<005), and for the latter there were better correlations (r=0 57, p<001) with ouabain-induced rate-independent reductions in both Q-S2 and left ventricular ejection time. 500 100 Rate -independent rise in dP/dt(mcx) (mmHg/s) Fig. 7 The relation between rate-independent changes in QS2 and dPIdt(max) induced by ouabain. Each point represents values obtained at one particular time after ouabain administration, and resultsfrom one patient are indicated by the same symbol.
Discussion
The difficulties in deriving a reliable measure of myocardial contractility in intact man have been reviewed by Mason et al.'0 Though there is no completely satisfactory method, it is generally accepted that measures derived from the rate of change of intraventricular pressure correlate well with contractility under most experimental conditions. 1-3
However, dP/dt (max) responds not only to change in contractility, but also to alteration in either the preload or afterload of the ventricle. In the left ventricle, preload and afterload are reflected by left ventricular end-diastolic pressure and aortic mean systolic pressure, respectively. With drugs such as isoprenaline which raise aortic systolic and reduce diastolic pressure, (dP/dt)/CPIP may be a more accurate measure of contractility, as it is independent of aortic blood pressure and is also unaffected by moderate changes in left ventricular end-diastolic pressure." This measure must be recorded during isovolumic systole, dP/dt being determined at any selected level of developed pressure common to control and intervention conditions. Like dP/dt (max) it is responsive to change in heart rate. The major limitation of either measure, however, is that they require cardiac catheterisation, and therefore cannot be used for studies of more than short duration, or in studies comparing the effects of several compounds or doses.
Determination of the duration of systole is a much more convenient procedure, is completely safe, and has been reported to provide a sensitive measure of change in cardiac performance. 4 Q-S2, left ventricular ejection time, and preejection period have been shown to be inversely related to heart rate in a group of healthy subjects with a wide range of resting heart rates.9 21 The slopes of regression equations relating systolic intervals to rate in these subjects were 2 1 to 2-4 for Q-S2, 1-7 for left ventricular ejection time, and 04 for pre-ejection period. The authors have proposed that indices of systolic intervals corrected for rate according to these regression slope values are applicable measures of altered myocardial contractility. These regression slopes, however, are very similar to those derived after infusion of isoprenaline, a powerful stimulant of cardiac beta-adrenergic receptors. This suggests that the wide range of resting heart rates reported in the earlier studies was associated with individual variation in sympathetic drive. It follows that rate-corrected indices derived from such a population will correct for the total effects of altered adrenergic stimulation. Such indices are not applicable to studies of other factors changing contractility, as they consistently over-correct for heart rate increases. As would be expected, the published rate-correction indices have been reported to be insensitive measures of the inotropic effects of catecholamines.22 When in our studies heart rate was increased by electrical pacing, significantly less shortening of systole was observed than predicted from the reported regression equations. Further, only the ejection phase of systole shortened. The relations of systolic intervals to altered heart rate are very similar during electrical pacing or after atropine administration.23 Atrial pacing slightly reduces left ventricular end-diastolic pressure and also slightly increases aortic diastolic pressure,24 and it is likely that these changes have some contributory effect upon systolic intervals. It seems reasonable, however, to attribute similar responses to the specific rate-increasing component of a drug's effect. Therefore, the regression equations relating systolic intervals to paced rate change appear more applicable to studies of drug effects than those based upon a range of resting heart rates.
No correction for drug-induced change in heart rate should be applied to pre-ejection period.25 The fact that pre-ejection period appears to be rate-independent is a considerable advantage, but unfortunately this is offset by the fact that it is a small, derived variable, and is particularly prone to technical error in measurement. This may account for the insignificant reduction in pre-ejection period recorded after ouabain administration. It has been suggested that the ratio of pre-ejection period to left ventricular ejection time may be a more suitable measure of myocardial performance,9 but this ratio appeared to be highly dependent upon rate change and increased substantially during electrical pacing. The interval of longest duration, Q-S2, is least affected by the technical difficulties in accurate determination, but must be corrected for change in heart rate. It is suggested that calculated rate-independent change in Q-S2 is the most reliable indicator of inotropic effect.
20ohnson, Meeran, Frank, Taylor
For the large changes produced by isoprenaline, there was an excellent inverse correlation for rateindependent changes in Q-S2 and dP/dt (max). The non-significant correlation for ouabain represents the smaller number of experiments to some extent, but the technical imprecision in measurement is more important with a drug producing only small to moderate increase in contractility. Though systolic intervals are dependent upon preload and afterload, they correlated equally well with dP/dt (max) and (dP/dt)/CPIP, possibly because both drugs induce a small change in preload or afterload relative to the increase in contractility. Determination of rateindependent change in Q-S2 appears to be a useful indication of moderate to large inotropic change induced by any drug which does not radically alter left ventricular end-diastolic pressure or aortic blood pressure. In studies of drug-induced inotropic effect, rate-dependent change in Q-S2 can be calculated by multiplying the recorded change in heart rate by the factor 1-13 derived from the patient group (Table 4) . Rate-independent change can be derived as the difference between the observed change in Q-S2 and the calculated rate-dependent change. It is preferable, however, that individual rate-dependence factors should be derived, as they appeared to be unique for each subject. This could be accomplished by recording Q-S2 at several heart rates after administration of atropine.
These adaptations of the techniques for determination of systolic intervals may provide a precise though not highly sensitive method of assessing the effect of drugs on myocardial contractility. The techniques are convenient enough to permit repetition. The observed degree of day-to-day variation in systolic intervals, however, probably reflects variation in the degree of sympathetic drive to the heart, and suggests that measurements would be valid only if recorded during a single day. 
